AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR LYMPHOID MALIGNANCIES IN PATIENTS OF 65 YEARS OLD AND BEYOND: A SINGLE CENTER FEASIBILITY EXPERIENCE. (November 2019)